About Core Diagnostics
Core Diagnostics is a company based in Gurugram (India) founded in 2012 was acquired by Metropolis India in December 2024. It operates as a Subscription Services, and HealthTech. Core Diagnostics has raised $17.26 million across 2 funding rounds from investors including Metropolis India, Eight Roads Ventures and F-Prime Capital. The company has 496 employees as of April 07, 2024. Core Diagnostics offers products and services including High-End Diagnostic Tests, Genetic Testing, and Subscription Health Plans. Core Diagnostics operates in a competitive market with competitors including Roche, Healthians, Quest Diagnostics, Agappe and LumiraDx, among others.
- Headquarter Gurugram, India
- Employees 496 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Core Diagnostics
- Date of Incorporation 28 Jun, 2012
- Jurisdiction Gurugram, Haryana, India
-
Annual Revenue
$11.27 M (USD)-10.79as on Mar 31, 2023
-
Net Profit
$-1.54 M (USD)-1418.31as on Mar 31, 2023
-
EBITDA
$-1.33 M (USD)-1054.48as on Mar 31, 2023
-
Total Equity Funding
$17.26 M (USD)
in 2 rounds
-
Latest Funding Round
$12.26 M (USD), Series B
Dec 01, 2016
-
Investors
Metropolis India
& 3 more
-
Employee Count
496
as on Apr 07, 2024
-
Acquired by
Metropolis India
(Dec 09, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Core Diagnostics
Core Diagnostics offers a comprehensive portfolio of products and services, including High-End Diagnostic Tests, Genetic Testing, and Subscription Health Plans. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced diagnostic tests for various medical conditions are provided.
Genetic tests for cardiovascular and endocrine disorders are offered.
Subscription plans for diabetes and hypertension management are available.
Unlock access to complete
Funding Insights of Core Diagnostics
Core Diagnostics has successfully raised a total of $17.26M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $12.26 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $12.3M
-
First Round
First Round
(01 Jun 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Series B - Core Diagnostics | Valuation |
investors |
|
| Jun, 2013 | Amount | Series A - Core Diagnostics | Valuation | Artiman |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Core Diagnostics
Core Diagnostics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Metropolis India, Eight Roads Ventures and F-Prime Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in technology and healthcare sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Core Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Core Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Core Diagnostics Comparisons
Competitors of Core Diagnostics
Core Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, Healthians, Quest Diagnostics, Agappe and LumiraDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| domain | founded_year | HQ Location |
Online platform for at home diagnostic tests and health checkups
|
|
| domain | founded_year | HQ Location |
Integrated diagnostic and IT services are provided to healthcare organizations.
|
|
| domain | founded_year | HQ Location |
In-vitro diagnostic reagents and equipment are manufactured and distributed.
|
|
| domain | founded_year | HQ Location |
Cloud based diagnostics platform for point of care diagnosing
|
|
| domain | founded_year | HQ Location |
Diagnostic company specializing in the manufacture of in-vitro diagnostic instruments and solutions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Core Diagnostics
Frequently Asked Questions about Core Diagnostics
When was Core Diagnostics founded?
Core Diagnostics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Core Diagnostics located?
Core Diagnostics is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Who is the current CEO of Core Diagnostics?
Dinesh Chauhan is the current CEO of Core Diagnostics.
Is Core Diagnostics a funded company?
Core Diagnostics is a funded company, having raised a total of $17.26M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jun 01, 2013.
How many employees does Core Diagnostics have?
As of Apr 07, 2024, the latest employee count at Core Diagnostics is 496.
What is the annual revenue of Core Diagnostics?
Annual revenue of Core Diagnostics is $11.27M as on Mar 31, 2023.
What does Core Diagnostics do?
Core Diagnostics is established as a premier diagnostic center in India, specializing in high-end diagnostic solutions. Services are provided across a wide range of medical fields including hereditary and sporadic cancers, hematological disorders, reproductive health, cardiovascular diseases, kidney diseases, urological disorders, ophthalmologic conditions, and neurological disorders. Advanced technologies such as molecular testing, immunohistochemistry, flow cytometry, histopathology, cytopathology, and cytogenetics are utilized to ensure precise and comprehensive diagnostic outcomes. The company is trusted by numerous doctors and has impacted many patient lives through innovative diagnostic approaches.
Who are the top competitors of Core Diagnostics?
Core Diagnostics's top competitors include Roche, Healthians and Quest Diagnostics.
What products or services does Core Diagnostics offer?
Core Diagnostics offers High-End Diagnostic Tests, Genetic Testing, and Subscription Health Plans.
Who are Core Diagnostics's investors?
Core Diagnostics has 4 investors. Key investors include Metropolis India, Eight Roads Ventures, F-Prime Capital, and Artiman.